CTO

CTO organizes and semantically integrates clinical trial terms using the Basic Formal Ontology (BFO) and OBO Foundry principles to enable interoperable representation and linking of trial data.

Key Features:

• PICO-based architecture: Implements the Population, Intervention, Comparator, Outcome (PICO) framework to structure clinical trial concepts.
• BFO foundation: Uses the Basic Formal Ontology (BFO) as its foundational framework to promote ontological rigor and interoperability.
• Term reuse: Reuses established terms from existing ontologies to ensure compatibility across biomedical resources.
• Trial-specific terminology: Defines numerous clinical trial–specific terms to represent trial entities and metadata.
• Data linking via PubChemRDF: Enables linking of chemical entities and drugs (exemplified by Gleevec) to multiple associated clinical trials in PubChemRDF.
• Text-mining integration: Supplies ontology terms for integration into search algorithms such as SCAIView to identify publications related to COVID-19 clinical trials.
• Complex dataset analysis: Supports linking and analysis of complex datasets related to clinical trials.

Scientific Applications:

• PubChemRDF linkage: Links a specific drug, Gleevec, with multiple associated clinical trials to integrate chemical and trial data.
• SCAIView text mining: Integrates CTO terms into SCAIView search algorithms to identify publications related to COVID-19 clinical trials.
• Clinical trial data organization and retrieval: Structures and organizes clinical trial metadata to support retrieval and downstream analyses.

Methodology:

CTO leverages the Basic Formal Ontology (BFO), reuses terms from existing ontologies, applies a PICO-based architecture, and exposes terms for use in PubChemRDF linking (e.g., Gleevec to trials) and integration into the SCAIView search algorithm for COVID-19 clinical trial text mining.